{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:39:22Z","timestamp":1791585562357,"version":"4.3.4"},"reference-count":92,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"University of Friboug"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Though microdosing psychedelics has become increasingly popular, its long-term effects on cardiac health remain unknown. Microdosing most commonly involves ingesting sub-threshold doses of lysergic acid diethylamide (LSD), psilocybin, or other psychedelic drugs 2\u20134 times a week for at least several weeks, but potentially months or years. Concerningly, both LSD and psilocybin share structural similarities with medications which raise the risk of cardiac fibrosis and valvulopathy when taken regularly, including methysergide, pergolide, and fenfluramine. 3,4-Methylenedioxymethamphetamine, which is also reportedly used for microdosing, is likewise associated with heart valve damage when taken chronically. In this review, we evaluate the evidence that microdosing LSD, psilocybin, and other psychedelics for several months or more could raise the risk of cardiac fibrosis. We discuss the relationship between drug-induced cardiac fibrosis and the 5-HT2B receptor, and we make recommendations for evaluating the safety of microdosing psychedelics in future studies.<\/jats:p>","DOI":"10.1177\/02698811231225609","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T06:01:27Z","timestamp":1705039287000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":45,"title":["Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins"],"prefix":"10.1177","volume":"38","author":[{"given":"Antonin","family":"Rouaud","sequence":"first","affiliation":[{"name":"University of Fribourg Center for Psychiatric Research, Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Calder","sequence":"additional","affiliation":[{"name":"University of Fribourg Center for Psychiatric Research, Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-0138","authenticated-orcid":false,"given":"Gregor","family":"Hasler","sequence":"additional","affiliation":[{"name":"University of Fribourg Center for Psychiatric Research, Fribourg, Switzerland"},{"name":"Lake Lucerne Institute, Vitznau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"bibr1-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20200"},{"key":"bibr2-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22385"},{"key":"bibr3-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5106-2"},{"key":"bibr4-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2013.02.003"},{"key":"bibr5-02698811231225609","first-page":"841","volume":"80","author":"Andreotti AC","year":"1995","journal-title":"J Clin Endocrinol Metabol"},{"key":"bibr6-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53717-1.01070-2"},{"key":"bibr7-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13981"},{"key":"bibr8-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.05.019"},{"key":"bibr9-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60252-X"},{"key":"bibr10-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200312001-00003"},{"key":"bibr11-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01779.x"},{"key":"bibr12-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/BF00614199"},{"key":"bibr13-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120918"},{"key":"bibr14-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/BF00547426"},{"key":"bibr15-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2020.1718250"},{"key":"bibr16-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02039-0"},{"key":"bibr17-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2013.12.004"},{"key":"bibr18-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"key":"bibr19-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.12.1721"},{"key":"bibr20-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.05.003"},{"key":"bibr21-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-013-3816-0"},{"key":"bibr22-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101629"},{"key":"bibr23-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2016.1278228"},{"key":"bibr24-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1511424"},{"key":"bibr25-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.06.045"},{"key":"bibr26-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.etp.2008.03.005"},{"key":"bibr27-02698811231225609","unstructured":"European Medicines Agency (2013) New restrictions on use of medicines containing ergot derivatives. European Medicines Agency\u2019s Committee for Medicinal Products for Human Use (CHMP). Available at: https:\/\/www.ema.europa.eu\/en\/news\/new-restrictions-use-medicines-containing-ergot-derivatives (accessed 10 July 2023)."},{"key":"bibr28-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1593561"},{"key":"bibr29-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1185\/03007998309112392"},{"key":"bibr30-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069103"},{"key":"bibr31-02698811231225609","unstructured":"FDA Public Health Advisory: Pergolide (marketed as Permax) (2007). Available at: https:\/\/web.archive.org\/web\/20070408111551\/https:\/www.fda.gov\/cder\/drug\/advisory\/pergolide.htm (accessed 8 July 2023)."},{"key":"bibr32-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1991.hed3107446.x"},{"key":"bibr33-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.89"},{"key":"bibr34-02698811231225609","first-page":"79","volume":"78","author":"Graham JR","year":"1967","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"bibr35-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196602172740701"},{"key":"bibr36-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12159"},{"key":"bibr37-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2004.09.014"},{"key":"bibr38-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.01.017"},{"key":"bibr39-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200603000-00005"},{"key":"bibr40-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.058057"},{"key":"bibr41-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz029"},{"key":"bibr42-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.10.002"},{"key":"bibr43-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21225"},{"key":"bibr44-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81446-7"},{"key":"bibr45-02698811231225609","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039040-00001"},{"key":"bibr46-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1177\/13634615221119386"},{"key":"bibr47-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391101"},{"key":"bibr48-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00176"},{"key":"bibr49-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-004-0951-4"},{"key":"bibr50-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.0829"},{"key":"bibr51-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01648.x"},{"key":"bibr52-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1349-6"},{"key":"bibr53-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320950567"},{"key":"bibr54-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.11.008"},{"key":"bibr55-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05477-0"},{"key":"bibr56-02698811231225609","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v2.i2.19"},{"key":"bibr57-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103099"},{"key":"bibr58-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0324-9"},{"key":"bibr59-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211050556"},{"key":"bibr60-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.56.5.889"},{"key":"bibr61-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-018-0116-7"},{"key":"bibr62-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.09-10-03482.1989"},{"key":"bibr63-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.039867"},{"key":"bibr64-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02884.x"},{"key":"bibr65-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.039883"},{"key":"bibr66-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2003.11.002"},{"key":"bibr67-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvc.2011.12.001"},{"key":"bibr68-02698811231225609","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114003"},{"key":"bibr69-02698811231225609","first-page":"207","volume":"296","author":"Pacifici R","year":"2001","journal-title":"J Pharm Exp Ther"},{"key":"bibr70-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1177\/0192623317690609"},{"key":"bibr71-02698811231225609","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198510040-00004"},{"key":"bibr72-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.806487"},{"key":"bibr73-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-4009-z"},{"key":"bibr74-02698811231225609","doi-asserted-by":"publisher","DOI":"10.2174\/15680266113139990039"},{"key":"bibr75-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14512-3"},{"key":"bibr76-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1177\/107385840000600408"},{"key":"bibr77-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.23.2836"},{"key":"bibr78-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062222"},{"key":"bibr79-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.6.1223"},{"key":"bibr80-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.01006.x"},{"key":"bibr81-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2009.05.002"},{"key":"bibr82-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.537"},{"key":"bibr83-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1006\/ebeh.2000.0132"},{"key":"bibr84-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231190865"},{"key":"bibr85-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.133348"},{"key":"bibr86-02698811231225609","unstructured":"U.S. Food and Drug Administration (2002) Cafergot suppositories approval letter. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2002\/09000_S022&S023_Cafergot_APPROVAL%20PACKAGE.pdf (accessed 10 July 2023)."},{"key":"bibr87-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00063-6"},{"key":"bibr88-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-020-0367-2"},{"key":"bibr89-02698811231225609","first-page":"720","volume":"276","author":"Wainscott DB","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr90-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0365"},{"key":"bibr91-02698811231225609","author":"Winstock A","year":"2021","journal-title":"Glob Drug Survey"},{"key":"bibr92-02698811231225609","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2014.10.010"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231225609","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811231225609","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231225609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:36Z","timestamp":1777507896000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811231225609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1177\/02698811231225609"],"URL":"https:\/\/doi.org\/10.1177\/02698811231225609","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]}}}